Torrance, CA5 Active Studies

Myalgic Encephalomyelitis Clinical Trials in Torrance, CA

Find 5 actively recruiting myalgic encephalomyelitis clinical trials in Torrance, CA. Connect with local research sites and explore new treatment options.

5
Active Trials
4
Sponsors
793
Enrolling

Recruiting Myalgic Encephalomyelitis Studies in Torrance

RecruitingTorrance, CANCT07011732

A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)

The purpose of this study is to evaluate the efficacy and safety of KarXT + KarX-EC in adult participants with agitation related to Alzheimer's Disease....

352 participants
Bristol-Myers Squibb
View Study Details
RecruitingTorrance, CANCT05156983

A Study of TAK-330 to Reverse the Effects of Factor Xa Inhibitors For Adults Needing Urgent Surgery

The aim of this study is to find out the effects of TAK-330 compared with four-factor prothrombin complex concentrate (4F-PCC) as part of standard treatment other than Prothromplex Total for anticoagu...

328 participants
Takeda
View Study Details
RecruitingTorrance, CANCT03949855

Belimumab With Rituximab for Primary Membranous Nephropathy

The primary objective of this study is to evaluate the effectiveness of belimumab and intravenous rituximab co-administration at inducing a complete or partial remission (CR or PR) compared to rituxim...

58 participants
National Institute of Allergy and Infectious Diseases (NIAID)
View Study Details
RecruitingTorrance, CANCT04889430

Efficacy and Safety of Iptacopan (LNP023) in Adult Patients With Atypical Hemolytic Uremic Syndrome Naive to Complement Inhibitor Therapy

The purpose of this Phase 3 study is to determine whether iptacopan (LNP023) is efficacious and safe for the treatment of aHUS in adult patients who are treatment naive to complement inhibitor therapy...

50 participants
Novartis Pharmaceuticals
View Study Details
RecruitingTorrance, CANCT05494593

A Study of ELAPRASE in Treatment-naïve Participants With Hunter Syndrome (Mucopolysaccharidosis [MPS] II)

The main aim of this study is to evaluate the ability of a prophylactic immune tolerizing regimen (ITR) to prevent or reduce the development of high titer anti-idursulfase antibodies in treatment-naïv...

5 participants
Takeda
View Study Details

About Myalgic Encephalomyelitis Clinical Trials in Torrance

Myalgic encephalomyelitis (ME/CFS) is a complex, chronic illness characterized by profound fatigue, post-exertional malaise, cognitive impairment, and sleep dysfunction. It affects millions worldwide and has no definitive diagnostic test or cure. Research is exploring immune, metabolic, and neurological mechanisms.

There are currently 5 myalgic encephalomyelitis clinical trials recruiting participants in Torrance, CA. These studies are seeking a combined 793 participants. Research is being sponsored by Bristol-Myers Squibb, Takeda, National Institute of Allergy and Infectious Diseases (NIAID) and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Myalgic Encephalomyelitis Clinical Trials in Torrance — FAQ

Are there myalgic encephalomyelitis clinical trials in Torrance?

Yes, there are 5 myalgic encephalomyelitis clinical trials currently recruiting in Torrance, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Torrance?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Torrance research site will contact you about next steps.

Are clinical trials in Torrance free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Torrance studies also compensate for your time and travel.

What myalgic encephalomyelitis treatments are being tested?

The 5 active trials in Torrance are testing new therapies including novel drugs, biologics, and treatment approaches for myalgic encephalomyelitis.

Data updated March 2, 2026 from ClinicalTrials.gov